MAZE

Insider trade Sale by Coloma Jason V (Chief Executive Officer)

5d ago

News Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.

14d ago

News Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock

14d ago

Insider trade Sale by Coloma Jason V (Chief Executive Officer)

14d ago

News Maze Therapeutics GAAP EPS of -$0.45 beats by $0.10, revenue of $20M beats by $11.5M

20d ago

News Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials

26d ago

Failures to deliver 50,000 shares failed to deliver

30d ago

Insider trade Sale by Atul Dandekar (CSBO)

31d ago

News Maze Therapeutics prices $150M equity offering

41d ago

News Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B

69d ago

News Maze Therapeutics falls despite positive mid-stage trial data for lead asset

69d ago

News Maze Therapeutics GAAP EPS of -$0.65 beats by $0.07

69d ago

News Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears

72d ago

Insider trade Sale by Harold Bernstein (President, R&D & CMO)

73d ago

Insider trade Sale by Harold Bernstein (President, R&D & CMO)

81d ago

Insider trade Sale by Harold Bernstein (President, R&D & CMO)

104d ago

Insider trade Sale by Amy Bachrodt (SVP, Finance)

104d ago

Insider trade Sale by Atul Dandekar (CSBO)

104d ago

Insider trade Sale by Amy Bachrodt

104d ago

News Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge

106d ago

Failures to deliver 127,228 shares failed to deliver

135d ago

News Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors

153d ago

Scanner Unusual volume (z=4.4)

160d ago

Scanner Unusual volume (z=4.5)

161d ago

Scanner Unusual volume (z=4.5)

163d ago